Skip to main content
Clinical Trials/NCT01556828
NCT01556828TerminatedNot Applicable

Analysis of Cutaneous and Hematologic Disorders by High-Throughput Nucleic Acid Sequencing

Stanford University1 site in 1 country70 target enrollmentStarted: June 2011Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Terminated
Enrollment
70
Locations
1
Primary Endpoint
Number of mutations

Study Overview

Brief Summary

The goal of this study is to identify genetic changes associated with the initiation, progression, and treatment response of response of cutaneous and hematologic disorders using recently developed high-throughput sequencing technologies. The improved understanding of the genetic changes associated with cutaneous and hematologic disorders may lead to improved diagnostic, prognostic and therapeutic options for these disorders.

Study Design

Study Type
Observational
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • 18 years of age or older
  • Patient meets the clinical and/or pathologic criteria for the cutaneous or hematologic disorder being examined.
  • Patient is willing to provide skin biopsies and five 10 mL tubes of peripheral blood.

Exclusion Criteria

  • Less than 18 years of age

Outcomes

Primary Outcomes

Number of mutations

Time Frame: 2 years

Identify mutations, changes in DNA copy number, structural rearrangements, or altered coding and non-coding RNA expression

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials